Raised plasma concentrations of α-defensins in patients with idiopathic pulmonary fibrosis

Thorax

Volumn 57, Issue 7, 2002, Pages 623-628

  Mukae, H ^a   Iiboshi, H ^b   Nakazato, M ^b   Hiratsuka, T ^b   Tokojima, M ^b   Abe, K ^b   Ashitani, J ^b   Kadota, J ^c   Matsukura, S ^b   Kohno, S ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; CARBON MONOXIDE; INTERLEUKIN 8;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; LUNG FUNCTION; LUNG LAVAGE; MALE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; VITAL CAPACITY;

ALPHA-DEFENSINS; BRONCHOALVEOLAR LAVAGE FLUID; CARBON MONOXIDE; FEMALE; FORCED EXPIRATORY VOLUME; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROTEOLIPIDS; PULMONARY FIBROSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RADIOIMMUNOASSAY; VITAL CAPACITY;

EID: 0036310907     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.7.623     Document Type: Article

References (35)

1. Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement
2. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis
3. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8
4. Relationship between cells obtained by bronchoalveolar lavage and survival in idiopathic pulmonary fibrosis
5. Computed tomography guided bronchoalveolar lavage in idiopathic pulmonary fibrosis
6. Bronchoalveolar lavage cellularity. Lone cryptogenic fibrasing alveolitis compared with the fibrosing alveolitis of systemic sclerosis
7. The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis
8. Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease
9. Determinants of progression in idiopathic pulmonary fibrosis
10. Determinants of survival in idiopathic pulmonary fibrosis
11. Neutrophil elastase:alpha-1-proteinase inhibitor complex in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis
12. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias
13. Defensins
14. Defensins. Key players or bystanders in infection, injury, and repair in the lung?
15. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections
16. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis
17. Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells
18. Purification and characterization of defensins from cystic fibrosis sputum
19. Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis
20. Plasma and BAL fluid concentrations of antimicrobial peptides in patients with Mycobacterium avium-intracellulare infection
21. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis
22. Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection
23. Isolation and sequence determinants of 6- and 8-kDa precursors of human neutrophil peptides from bone marrow, plasma and peripheral blood neutrophils
24. Serum surfactant protein A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent
25. KL-6: A serum marker for interstitial pneumonia
26. Localization of human neutrophil peptide (HNP) and its messenger RNA in neutrophil series
27. Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice
28. Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation
29. Neutrophil endothelitis in patients with idiopathic pulmonary fibrosis
30. Elevated pleural fluid levels of defensins in patients with empyema
31. Effect of defensins on interleukin-8 synthesis in airway epithelial cells
32. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity
33. Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis
34. Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis
35. Recombinant granulocyte colony-stimulating factor induces production of human neutrophil peptides in lung cancer patients with neutropenia